Assembly Biosciences ASMB Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Assembly Biosciences in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Assembly Biosciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Assembly Biosciences's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Assembly Biosciences's total equity?
- Assembly Biosciences (ASMB) reported total equity of $198.61M in Q1 2026.
- How has Assembly Biosciences's total equity changed year-over-year?
- Assembly Biosciences's total equity increased by 632.0% year-over-year, from $27.13M to $198.61M.
- What is the long-term trend for Assembly Biosciences's total equity?
- Over 5 years (2020 to 2025), Assembly Biosciences's total equity has grown at a -3.0% compound annual growth rate (CAGR), from $240.58M to $206.75M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.